Yue H, Febbraio M, Klenotic P, Kennedy D, Wu Y, Chen S
Arterioscler Thromb Vasc Biol. 2018; 39(2):263-275.
PMID: 30567481
PMC: 6345504.
DOI: 10.1161/ATVBAHA.118.312186.
Ostergren C, Shim J, Larsen J, Nielsen L, Bentzon J
PLoS One. 2015; 10(4):e0121899.
PMID: 25875831
PMC: 4395357.
DOI: 10.1371/journal.pone.0121899.
Ruohonen S, Abe K, Kero M, Toukola L, Ruohonen S, Roytta M
Peptides. 2009; 30(4):715-20.
PMID: 19135490
PMC: 2914533.
DOI: 10.1016/j.peptides.2008.12.009.
Doorenbos C, Tsaih S, Sheehan S, Ishimori N, Navis G, Churchill G
Genetics. 2008; 179(1):693-9.
PMID: 18493081
PMC: 2390645.
DOI: 10.1534/genetics.107.085142.
Peters L, Zhang W, Lambert A, Brugnara C, Churchill G, Platt O
Mamm Genome. 2005; 16(10):749-63.
PMID: 16261417
DOI: 10.1007/s00335-005-0063-6.
PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, Percevault F
J Clin Invest. 2005; 115(11):3228-38.
PMID: 16239970
PMC: 1257531.
DOI: 10.1172/JCI22756.
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.
Hamann L, Gomma A, Schroder N, Stamme C, Glaeser C, Schulz S
J Mol Med (Berl). 2005; 83(6):478-85.
PMID: 15875151
DOI: 10.1007/s00109-005-0643-7.
RAGE: a novel target for drug intervention in diabetic vascular disease.
Hudson B, Schmidt A
Pharm Res. 2004; 21(7):1079-86.
PMID: 15290845
DOI: 10.1023/b:pham.0000032992.75423.9b.
Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen.
Li T, Larrucea S, Souza S, Leal S, Lopez J, Rubin E
Blood. 2004; 103(9):3396-402.
PMID: 14739220
PMC: 6148756.
DOI: 10.1182/blood-2003-10-3721.
A model of primary atherosclerosis and post-angioplasty restenosis in mice.
Leidenfrost J, Khan M, Boc K, Villa B, Collins E, Parks W
Am J Pathol. 2003; 163(2):773-8.
PMID: 12875996
PMC: 1868197.
DOI: 10.1016/S0002-9440(10)63704-2.
